Menu

Cytokinetics, Incorporated CYTK

Full chart Compare
Set alert

Price alert · CYTK

All alert types
53.69 USD -1.86 (-3.35%)

At closeNov 6, 2026, 6:37 PM EST

53.99 +0.30 +0.56%

After hours · Nov 6, 6:37 PM ET

53.55 Day range 56.51
53.69 52-week range 87.26
YTD
-15.50%
1 year
-10.96%

Revenue & Expenses

Revenue → Gross Profit: $77.91MGross Profit → Expenses: $77.91MRevenue → Cost of Revenue: $10.13MExpenses → Selling, General & Admin: $284.27MExpenses → Research & Development: $405.90MExpenses → Interest Expense: $103.87MExpenses → Other Expenses: $68.83MNet Loss → Expenses: $784.96MGross Profit$77.91MNet Loss$784.96MCost of Revenue$10.13MExpenses$862.87MSelling, General & Admin$284.27MResearch & Development$405.90MInterest Expense$103.87MOther Expenses$68.83MRevenue$88.04M

Latest period ending Dec 31, 2025 · select a line to chart its full history

CYTK annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
88.04M18.47M7.53M94.59M70.43M
88.04M18.47M7.53M94.59M70.43M
-612.26M-536.25M-496.20M-324.20M-186.31M
-784.96M-589.53M-526.24M-388.95M-215.31M
-6.54-5.26-5.45-4.33-2.80
CYTK annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
122.52M94.86M113.02M65.58M112.67M
1.42B1.40B824.32M1.01B841.32M
2.08B1.54B1.21B1.12B597.46M
1.28B788.68M755.77M750.30M269.93M
-659.63M-135.37M-386.32M-107.90M243.86M
CYTK annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-510.01M-395.89M-414.33M-299.52M-142.52M
16.67M-553.10M239.25M-262.13M-147.78M
524.46M930.61M221.32M516.17M319.98M
-24.81M-3.91M-1.42M-11.34M-48.87M
30.40M-18.17M46.22M-45.48M29.68M